Advertisement
Advertisement

DYAI

DYAI logo

Dyadic International, Inc.

0.89
USD
Sponsored
-0.02
-2.10%
Jan 30, 10:56 UTC -5
Closed
exchange

After-Market

0.91

+0.02
+2.60%

DYAI Earnings Reports

Positive Surprise Ratio

DYAI beat 9 of 22 last estimates.

41%

Next Report

Date of Next Report
Mar 24, 2026
Estimate for Q4 25 (Revenue/ EPS)
$1.37M
/
-$0.04
Implied change from Q3 25 (Revenue/ EPS)
+17.63%
/
-33.33%
Implied change from Q4 24 (Revenue/ EPS)
+67.73%
/
-20.00%

Dyadic International, Inc. earnings per share and revenue

On Nov 12, 2025, DYAI reported earnings of -0.06 USD per share (EPS) for Q3 25, missing the estimate of -0.04 USD, resulting in a -35.75% surprise. Revenue reached 1.17 million, compared to an expected 1.12 million, with a 3.83% difference. The market reacted with a -3.87% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 4 analysts forecast an EPS of -0.04 USD, with revenue projected to reach 1.37 million USD, implying an decrease of -33.33% EPS, and increase of 17.63% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Regeneron Pharmaceuticals Inc
Report Date
Jan 30, 2026 For Q4 25
Estimate
$10.84
Actual
$11.44
Surprise
+5.52%
logo
Nurix Therapeutics, Inc. Common stock
Report Date
Jan 28, 2026 For Q4 25
Estimate
-$0.88
Actual
-$0.82
Surprise
+7.66%
FAQ
For Q3 2025, Dyadic International, Inc. reported EPS of -$0.06, missing estimates by -35.75%, and revenue of $1.17M, 3.83% above expectations.
The stock price moved down -3.87%, changed from $0.94 before the earnings release to $0.91 the day after.
The next earning report is scheduled for Mar 24, 2026.
Based on 4 analysts, Dyadic International, Inc. is expected to report EPS of -$0.04 and revenue of $1.37M for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement